Rimegepant, also known as BMS-927711 and BHV-3000, is a potent, selective, competitive, and orally active calcitonin gene-related peptide (CGRP) antagonist in clinical trials for treating migraines. Rimegepant has shown in vivo efficacy without vasoconstriction effect. BMS-927711 is superior to placebo at several different doses (75 mg, 150 mg, and 300 mg) and has an excellent tolerability profile.
Molecular Weight:
1221.2526
CAS Number:
[1374024-48-2]
Formula:
C56H64F4N12O13S
Target:
Others|||CGRP Receptor
T70837
* VAT and and shipping costs not included. Errors and price changes excepted
